Abstract:OBJECTIVE:To investigate the relationship between serum VEGF (sVEGF) level and VEGF, COX-2 and MVD expression in breast cancer, and to discuss their role in angiogensis of breast cancer.METHODS:sVEGF level was detected by ELISA in 68 preoperative breast cancer, 35 benign breast disease and 20 healthy women. The expression of VEGF, COX-2 and MVD was detected by immunohistochemical method in tissues of breast cancer and breast benign diseases, and to analyze the relationship of sVEGF, VEGF, COX-2 and MVD.RESULTS:(1) sVEGF level in preoperative breast cancers was 306.51 pg/ml (interquartile range from 190.44 to 442.04 pg/ml), in benign diseases was 150.82 pg/ml (interquartile range from 82.36 to 212.34 pg/ml), and in healthy control was 105.93 pg/ml (interquartile range from 78.54 to 157.77 pg/ml). The sVEGF level of preoperative breast cancer group was significantly higher than that of breast benign disease group and healthy women (P = 0.001). (2) The VEGF expression positive rate in breast cancer (67.65%) was significantly higher than that in breast benign disease (44.12%) (P = 0.015). The COX-2 expression positive rate in breast cancer (42.86%) was significantly higher than that in breast benign disease (11.43%) (P = 0.002). (3) the COX-2 expression positive rate in sVEGF high level patients (56.00%) was significantly higher than that in sVEGF normal level patients (11.11%) (P = 0.024), and MVD in sVEGF high level patients (27.32 +/- 3.40) was also higher than that in sVEGF normal level patients (15.31 +/- 6.16) (P = 0.011). (4) The sVEGF level (322.09 +/- 79.31) of 68 breast cancer patients whose VEGF was positive in breast cancer tissues was significantly higher than that in VEGF negative group (222.47 +/- 73.53) (P = 0.017). (5) The COX-2 expression positive rate in VEGF positive expression group (65.21%) was significantly higher than that in VEGF negative expression group (18.18%) (P = 0.017). The MVD expression in COX-2 positive expression group (22.94 +/- 5.51) was significantly higher than that in COX-2 negative expression group (10.30 +/- 4.42) (P = 0.027).CONCLUSION:sVEGF level in breast cancer is significantly higher than that in breast benign disease and healthy women, and is correlated with the expression of COX-2 and MVD in breast cancer tissues.

Correlation Between Mammographic Signs and Expression of Vascular Endothelial Growth Factor (VEGF) and Microvessel Density(MVD) in Breast Cancer

The correlation of VEGF expression with MVD in renal pelvic carcinoma and its clinical significance

Clinical significance of microvessel density and vascalar endothelial growth factor in primary breast cancer

Expression of Vascular Endothelial Growth Factor (VEGF) in Breast

Expression of Vascular Endothelial Growth Factor and Microvessel Density in Breast Carcinoma Paracancerous Tissues and Clinical Implication

The relationship between preoperative serum VEGF-A and cancer tissue MVD in breast cancer

Relationship Between Vascular Endothelial Growth Factor and Microvascular Density with Lymph Node Metastasis in Breast Carcinoma

Evaluation of vascular endothelial growth factor and tumor microvessel density in prognoses of patients with breast cancer: A follow-up of 1-10 years

The relationship of vascular endothelial growth factor and micro vascular density with the invasion, metastasis and prognosis of colorectal carcinoma

[Tumor Angiogenesis in Node-Negative Breast Carcinoma].

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Vascular Endothelial Growth Factor Expression in Invasive Ductal Carcinoma of Breast

Relationship Between the VEGF and Pathological Factor As Well As Prognostic Significance in Breast Cancer

The Expression and Clinical Significance of Vascular Endothelial Growth Factor-C in Gastric Cancer Tissues

Biological Significance Between Levels of VEGF-C in Serum and Tissue of Tumor and Lymph Vessel Density in Breast Cancer Patients

Clinical study of microvessel density and vascular endothelial growth factor in colorectal cancers

Correlation of Dynamic Contrast Enhancement MRI Semi-quantitative Parameters with VEGF in Breast Disease

Relationship Between Serum VEGF Level and VEGF, COX-2 and MVD Expression in Breast Cancer Tissues

Correlations Between Microvessel Density and Angio with AxillaryLymph Node Metastasis in Patients with Primary Breast Carcinoma

Expression and significance of IL-8 and MVD in the tissue of breast carcinoma

Correlation between power Doppler vascularity index and microvessel density of breast masses